MarketPulse

respiratory infections

3 articles
BenzingaBenzinga··Prnewswire

Roche Expands Respiratory Diagnostics with Faster, Broader Pathogen Detection Panel

Roche launches cobas eplex RP3, detecting 25 pathogens simultaneously across CE markets, enabling faster clinical decisions and improved patient outcomes.
RHHBYhealthcare innovationrespiratory infections
GlobeNewswire Inc.GlobeNewswire Inc.··Beyond Air, Inc.

Beyond Air to Present Nitric Oxide Pipeline at Roth Conference

Beyond Air ($XAIR) will present at the 38th Annual Roth Conference in March, showcasing its nitric oxide therapy platform for respiratory and oncology applications.
XAIRbiopharmaceuticalmedical device
GlobeNewswire Inc.GlobeNewswire Inc.··Beyond Air, Inc.

Peer-Reviewed Study Validates High-Dose Inhaled Nitric Oxide for Respiratory Infections

Peer-reviewed study validates Beyond Air's high-dose inhaled nitric oxide for treating respiratory infections including pneumonia, COVID-19, and bronchiolitis, supporting regulatory advancement.
XAIRclinical trialshigh-dose inhaled nitric oxide